Locus Cell, Taiwan-Based Cell and Gene Therapy CDMO, Signs MoU with Charles River at APAC Biomanufacturing Leadership Summit

2026-03-12 - 00:36

SINGAPORE, March 12, 2026 /PRNewswire/ — Locus Cell Co., Ltd. (“Locus Cell”), a Taiwan-based cell and gene therapy (CGT) Contract Development and Manufacturing Organization (CDMO), and Charles River Laboratories (“Charles River”), a global contract research organization (CRO) providing drug development support and biologics testing solutions, have signed a Memorandum of Understanding (MoU) during the APAC